Capital Fund Management (CFM)’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
TCM
BBA
Capital Fund Management (CFM)'s BLUE Position: Q2 2022 in Review
Capital Fund Management (CFM) sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 12,908 shares — an estimated $1.25M sold.
Capital Fund Management (CFM) first reported a position in BLUE in Q2 2015 and held it in 14 quarters. The position peaked at $16.6M in Q4 2015. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.
- Capital Fund Management (CFM) reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
- Capital Fund Management (CFM) sold 12,908 bluebird bio shares in Q2 2022, an estimated $1.25M.
- Capital Fund Management (CFM) first reported a position in bluebird bio in Q2 2015 and held it in 14 quarters.
- Capital Fund Management (CFM)'s bluebird bio position peaked at $16.6M in Q4 2015.
- 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2022, filed 12 Aug 2022.